🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseNon-invasive MASH biomarkers — March 2026 Page 9

Non-invasive MASH biomarkers — March 2026

AttorneyGrant Thu, Feb 8, 2024 at 1:03 AM 54 replies 3,138 viewsPage 9 of 11
mel_PDX
Member
189
890
Dec 2024
Portland, OR
Oct 18, 2024 at 11:45 PM#41
Dr.SleepRoch said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

There is a second half to this that has not been said yet. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

35 8Dr.NateNeph, PharmD_Rodriguez, julia.endo and 32 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Oct 30, 2024 at 2:32 AM#42

The figures, for anyone assembling their own picture. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

36 9stefan_berlin, Dr.EM_Chicago, pete_RVA and 33 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Nov 10, 2024 at 5:13 AM#43

Moderator note: the sourcing question belongs in the vendor section and has been split out. No action needed from anybody.

37 10DoseLogDan, SleepFixSam, PurityPaulOR and 34 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Nov 21, 2024 at 7:47 AM#44
TrialTracker_MD said:
One habit that pays for itself: post the method alongside the number.

I do not accept the framing. The question has been narrowed to the version that has a tidy answer, and the part that was dropped is the part the OP actually asked about.

38 11PurityPaulOR, MaxMetOK, MounjBrad and 35 others
Reply Quote Save Share Report
steph_laguna
Member
234
1,123
Nov 2024
Laguna Beach, CA
Dec 2, 2024 at 10:15 AM#45
TrialTracker_MD said:
One habit that pays for itself: post the method alongside the number.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

I would rather be corrected than agreed with, if it comes to it.

39 12marco_milano, pam_columbus, nick_SD_fit and 36 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register